is citicholine or centro preferable for some reason, since they both seem to work the same, for me?
There is a huge advantage to take centrophenoxine a.k.a. meclofenoxate over CDP-choline a.k.a. citicoline!
What is this advantage you may ask? Well, the absolutely fabulous drug
centrophenoxine is an anti-lipofusin drug. You see, as your brain ages, your brain cells acquire dark, age-related deposits (junk) called lipofuscin. To keep your brain young, you want to keep your lipofuscin level low.
http://www.ncbi.nlm....Pubmed_RVDocSumAge-related decline in multiple unit action potentials of cerebral cortex correlates with the number of lipofuscin-containing neurons.
Sharma D, Singh R.
Neurobiology Laboratory, School of Life Sciences, Jawaharlal Nehru University, New Delhi, India.
The present study examined whether there is any obvious correlation between the density of lipofuscin-containing neurons and the spontaneous neuronal action potentials (Multiple Unit Activity, MUA) in the parietal cortex of the aging rat brain. The results showed that MUA counts were decreased with age while the number of lipofuscin-containing neurons was increased. The cortex with the highest percentage of lipofuscin-containing neurons had the lowest MUA counts while the cortex with the lowest percentage of lipofuscin-containing neurons had the highest MUA counts. The inverse correlation between MUA and lipofuscin-containing neuron number was also evident when the population of the lipofuscin-containing neurons was pharmacologically altered in vivo by the administration of anti-lipofuscin drug centrophenoxine. The inverse relationship between MUA and the lipofuscin-containing neuron numbers is consistent with: (i) the correlations of MUA with age-related changes in lipid peroxidation and biochemically measured lipofuscin concentration, and (ii) the oxidative stress-induced impairments of neuronal electrophysiology.
PMID: 8979484 [PubMed - indexed for MEDLINE]
http://www.ncbi.nlm....Pubmed_RVDocSumBrain lipofuscinolysis and ceroidolysis--to be or not to be.
Riga D, Riga S.
Institute of Neurology and Psychiatry, Bucharest, Romania.
Lipofuscin pigment (LP) accumulations and ceroid pigment (CP) storages were demonstrated by multiple consensus studies. On the contrary, fewer researches, sometimes with opposite conclusions were made on brain LP and CP decrease, dissolution and elimination. Neuroactive agents (such as Meclofenoxate, Orotic acid, Antagonic-Stress, Piracetam, L-Deprenyl, Geriforte) generate LP and CP decrease and dissolution by cytoplasm rehydration, optimization of the brain cellular recycling system activities, by neuronal, glial and capillary LP lysis and CP lysis, by neurono-glio-endothelial transfer of highly processed LP and CP, with final capillary elimination. Therefore, these nootropic drugs may become therapeutical solutions in brain aging deceleration, in CP inductive circumstances and in age-associated diseases.
PMID: 8821338 [PubMed - indexed for MEDLINE]
This doesn't just remove nasty lipofuscin from your brain, but it removes lipofuscin from your entire body. As you age, your whole body acquires these horrid cellular waste deposits!http://www.ncbi.nlm....Pubmed_RVDocSumLipofuscin accumulation in ageing myocardium & its removal by meclophenoxate.
Patro N, Sharma SP, Patro IK.
Department of Zoology, Kurukshetra University.
A study was undertaken on the age-associated histochemical changes in the ventricular myocardium and the influence of meclophenoxate hydrochloride (MPH) on the age pigment lipofuscin. Sixty Wistar albino rats in three age-groups (3, 15 and 30 months old) were treated with meclophenoxate hydrochloride (100 mg/kg body wt/day, ip) for a period of 2-8 wk. Five animals each from the three age-groups served as controls. Various histochemical and micromorphometric studies were carried out on the myocardial tissue. A linear increase in the myocardial volume occupied by the pigment was observed with advancing age. As a result of meclophenoxate treatment, a gradual decrease in the myocardial volume occupied by the pigment was noted. After 4-6 wk treatment, the pigment bodies were found lodged into the capillary endothelium and the lumen, facilitating the removal of the pigment via blood stream. Histochemical and micromorphometric analyses of ventricular myocardium of albino rats have shown thus that deposition of the age-pigment, lipofuscin, can be accepted as an index of cellular ageing.
PMID: 1512044 [PubMed - indexed for MEDLINE]
I can't believe I've thus failed to mention that centrophenoxine enhances your brain anti-oxidant systems within your brain! How could I have?http://www.ncbi.nlm....Pubmed_RVDocSumEffect of centrophenoxine on the antioxidative enzymes in various regions of the aging rat brain.
Roy D, Pathak DN, Singh R.
This study investigated the effect (in vivo) of centrophenoxine (Helfergin) on the activity of antioxidant enzymes (glutathione peroxidase GSH-PER, glutathione reductase GSSG-RED, superoxide dismutase SOD and catalase) in subcellular fractions from the regions of the brain (cerebrum, cerebellum and brain stem) of rats aged 6, 9 and 12 months. In all age groups, normal (control) activity of GSH-PER, GSSG-RED and SOD in the three brain regions was higher in the soluble fractions than in the particulate fractions. The three regions of the brain showed different levels of the enzyme activities. Enzymes in soluble fractions (except GSSG-RED in cerebrum of rats aged 12 months) did not change with age. In particulate fractions, however, the enzymes showed age-related changes: GSH-PER decreased with age in cerebellum and brain stem, but showed an age-related increase in cerebrum, GSSG-RED and SOD increased with age in all the three brain regions. Catalase activity in all the three brain regions remained unchanged in all age groups. Six week administration of centrophenoxine (once a day in doses of 80 mg/Kg and 120 mg/Kg) to the experimental animals produced increases in the activity of SOD, GSH-PER and GSSG-RED in particulate fractions from all the three brain regions. In the soluble fractions, however, only SOD and GSH-PER activity was increased. In vitro also centrophenoxine stimulated the activity of GSH-PER. A dosage of 80 mg/Kg produced greater changes than a 120 mg/Kg dosage. The drug had no effect on the activity of catalase. Centrophenoxine also reduced lipofuscin deposits (studied both biochemically and histochemically) thus indicating that the drug inhibited lipofuscin accumulation by elevating the activity of the antioxidant enzymes. The data suggest that alleviation of senescence by centrophenoxine may, at least, partly be due to activation by it of antioxidant enzymes.
PMID: 6416880 [PubMed - indexed for MEDLINE]
There are
many many many more studies on pubmed. I suggest you search for more.
You will also notice that there are no, I repeat no negative studies on centrophenoxine out there! Do your brain and body a favor and get on some centro today!